Scienture Holdings, Inc. (Nasdaq: SCNX) announced a securities purchase agreement with institutional investors for the purchase of 3,225,000 shares of common stock.
The offering price is set at $1.20 per share, with gross proceeds expected to be about $3.9 million before deducting expenses.
The offering is anticipated to close on August 15, 2025, subject to customary conditions.
Offer Details
3,225,000 shares of common stock to be purchased at $1.20 per share.
Proceeds
Expected gross proceeds of approximately $3.9 million before expenses.
Closing Date
The offering is set to close on August 15, 2025, subject to standard closing conditions.
- The offering provides Scienture Holdings, Inc. with additional capital for strategic initiatives and operational expansion.
- This move reflects investor confidence in the company and its future growth prospects.
The Registered Direct Offering of common stock by Scienture Holdings, Inc. signifies a step towards strengthening its financial position and supporting its growth strategy in the pharmaceutical industry.